Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
SALMETEROL XINAFOATE
(1994)
Small molecule
Beta-2 adrenergic receptor agonist
Unknown
Approved
Asthma; Asthma, Exercise-Induced; Bronchial Spasm; Bronchitis, Chronic; Emphysema; Pulmonary Disease, Chronic Obstructive
SALMETEROL XINAFOATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
6EW8Q962A5
Molecule Type:
Small molecule
Molecular Formula:
C36H45NO7
Molecular Weight:
603.76
AlogP:
4.11
PSA:
81.95
HBD:
4.0
HBA:
#RotB:
16.0
Source:
ACRIVASTINE
(1994)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Hypersensitivity
ACRIVASTINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
A20F9XAI7W
Molecule Type:
Small molecule
Molecular Formula:
C22H24N2O2
Molecular Weight:
348.45
AlogP:
4.02
PSA:
53.43
HBD:
1.0
HBA:
#RotB:
6.0
Source:
IOBENGUANE
(1994)
Small molecule
Unknown
Unknown
Approved
Unknown
IOBENGUANE
×
Maximum Phase:
4
First Approval:
1994
UNII:
35MRW7B4AD
Molecule Type:
Small molecule
Molecular Formula:
C8H10IN3
Molecular Weight:
275.09
AlogP:
1.27
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
LAMOTRIGINE
(1994)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Bipolar Disorder; Depressive Disorder; Epilepsies, Partial; Epilepsy; Epilepsy, Tonic-Clonic; Lennox Gastaut Syndrome; Seizures
LAMOTRIGINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
U3H27498KS
Molecule Type:
Small molecule
Molecular Formula:
C9H7Cl2N5
Molecular Weight:
256.1
AlogP:
2.01
PSA:
90.71
HBD:
2.0
HBA:
#RotB:
1.0
Source:
FLUVOXAMINE
(1994)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
FLUVOXAMINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
O4L1XPO44W
Molecule Type:
Small molecule
Molecular Formula:
C15H21F3N2O2
Molecular Weight:
318.34
AlogP:
3.2
PSA:
56.84
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PHENIRAMINE
(1994)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity; Pruritus
PHENIRAMINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
134FM9ZZ6M
Molecule Type:
Small molecule
Molecular Formula:
C16H20N2
Molecular Weight:
240.35
AlogP:
3.17
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TACROLIMUS
(1994)
Small molecule
FK506-binding protein 1A inhibitor
INJECTION; ORAL; TOPICAL
Approved
Eczema; Immune System Diseases
TACROLIMUS
×
Maximum Phase:
4
First Approval:
1994
UNII:
WM0HAQ4WNM
Molecule Type:
Small molecule
Molecular Formula:
C44H69NO12
Molecular Weight:
804.03
AlogP:
4.64
PSA:
178.36
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BUDESONIDE
(1994)
Small molecule
Glucocorticoid receptor agonist
INHALATION; NASAL; ORAL; RECTAL
Approved
Asthma; Bronchitis, Chronic; Colitis, Ulcerative; Crohn Disease; Emphysema; Lung Diseases, Obstructive; Nasal Obstruction; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
BUDESONIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
Q3OKS62Q6X
Molecule Type:
Small molecule
Molecular Formula:
C25H34O6
Molecular Weight:
430.54
AlogP:
2.72
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NEFAZODONE HYDROCHLORIDE
(1994)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depression; Depressive Disorder, Major
NEFAZODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
27X63J94GR
Molecule Type:
Small molecule
Molecular Formula:
C25H33Cl2N5O2
Molecular Weight:
506.48
AlogP:
3.55
PSA:
55.53
HBD:
0.0
HBA:
#RotB:
10.0
Source:
NALMEFENE
(1995)
Small molecule
Unknown
Unknown
Approved
Alcoholism
NALMEFENE
×
Maximum Phase:
4
First Approval:
1995
UNII:
TOV02TDP9I
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO3
Molecular Weight:
339.44
AlogP:
2.51
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
2.0
Source:
CISATRACURIUM BESYLATE
(1995)
Small molecule
Muscle-type nicotinic acetylcholine receptor antagonist
INJECTION
Approved
Unknown
CISATRACURIUM BESYLATE
×
Maximum Phase:
4
First Approval:
1995
UNII:
80YS8O1MBS
Molecule Type:
Small molecule
Molecular Formula:
C65H82N2O18S2
Molecular Weight:
1243.5
AlogP:
8.07
PSA:
126.44
HBD:
0.0
HBA:
#RotB:
24.0
Source:
NALMEFENE HYDROCHLORIDE
(1995)
Small molecule
Opioid receptors; mu/kappa/delta antagonist
Unknown
Approved
Unknown
NALMEFENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
K7K69QC05X
Molecule Type:
Small molecule
Molecular Formula:
C21H26ClNO3
Molecular Weight:
375.9
AlogP:
2.51
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IBUTILIDE
(1995)
Small molecule
Unknown
Unknown
Approved
Arrhythmias, Cardiac
IBUTILIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
2436VX1U9B
Molecule Type:
Small molecule
Molecular Formula:
C20H36N2O3S
Molecular Weight:
384.59
AlogP:
4.16
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
14.0
Source:
MOEXIPRIL
(1995)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
MOEXIPRIL
×
Maximum Phase:
4
First Approval:
1995
UNII:
WT87C52TJZ
Molecule Type:
Small molecule
Molecular Formula:
C27H34N2O7
Molecular Weight:
498.58
AlogP:
2.58
PSA:
114.4
HBD:
2.0
HBA:
#RotB:
11.0
Source:
DEXRAZOXANE
(1995)
Small molecule
DNA topoisomerase II inhibitor
Unknown
Approved
Unknown
DEXRAZOXANE
×
Maximum Phase:
4
First Approval:
1995
UNII:
048L81261F
Molecule Type:
Small molecule
Molecular Formula:
C11H16N4O4
Molecular Weight:
268.27
AlogP:
-2.71
PSA:
98.82
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MYCOPHENOLATE MOFETIL
(1995)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
ORAL
Approved
Unknown
MYCOPHENOLATE MOFETIL
×
Maximum Phase:
4
First Approval:
1995
UNII:
9242ECW6R0
Molecule Type:
Small molecule
Molecular Formula:
C23H31NO7
Molecular Weight:
433.5
AlogP:
2.52
PSA:
94.53
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TRIMETHOPRIM HYDROCHLORIDE
(1995)
Small molecule
Bacterial dihydrofolate reductase inhibitor
ORAL
Approved
Unknown
TRIMETHOPRIM HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
9XE000OU9B
Molecule Type:
Small molecule
Molecular Formula:
C14H19ClN4O3
Molecular Weight:
326.78
AlogP:
1.26
PSA:
105.51
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CETIRIZINE
(1995)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Hypersensitivity
CETIRIZINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
YO7261ME24
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CEFTIBUTEN
(1995)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Bacterial Infections; Bronchitis, Chronic; Otitis Media
CEFTIBUTEN
×
Maximum Phase:
4
First Approval:
1995
UNII:
IW71N46B4Y
Molecule Type:
Small molecule
Molecular Formula:
C15H14N4O6S2
Molecular Weight:
410.43
AlogP:
-0.05
PSA:
162.92
HBD:
4.0
HBA:
#RotB:
6.0
Source:
NISOLDIPINE
(1995)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Cardiovascular Diseases; Hypertension
NISOLDIPINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
4I8HAB65SZ
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O6
Molecular Weight:
388.42
AlogP:
3.2
PSA:
107.77
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CETIRIZINE HYDROCHLORIDE
(1995)
Small molecule
Histamine H1 receptor antagonist
INJECTION; OPHTHALMIC; ORAL
Approved
Rhinitis, Allergic, Seasonal; Urticaria
CETIRIZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
64O047KTOA
Molecule Type:
Small molecule
Molecular Formula:
C21H27Cl3N2O3
Molecular Weight:
461.82
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
GLIMEPIRIDE
(1995)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
GLIMEPIRIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
6KY687524K
Molecule Type:
Small molecule
Molecular Formula:
C24H34N4O5S
Molecular Weight:
490.63
AlogP:
3.07
PSA:
124.68
HBD:
3.0
HBA:
#RotB:
7.0
Source:
MOEXIPRIL HYDROCHLORIDE
(1995)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Approved
Hypertension
MOEXIPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
Q1UMG3UH45
Molecule Type:
Small molecule
Molecular Formula:
C27H35ClN2O7
Molecular Weight:
535.04
AlogP:
2.58
PSA:
114.4
HBD:
2.0
HBA:
#RotB:
11.0
Source:
TRAMADOL
(1995)
Small molecule
Unknown
Unknown
Approved
Pain
TRAMADOL
×
Maximum Phase:
4
First Approval:
1995
UNII:
39J1LGJ30J
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO2
Molecular Weight:
263.38
AlogP:
2.63
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TRAMADOL HYDROCHLORIDE
(1995)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Acute Pain; Chronic Pain; Pain; Substance-Related Disorders
TRAMADOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
9N7R477WCK
Molecule Type:
Small molecule
Molecular Formula:
C16H26ClNO2
Molecular Weight:
299.84
AlogP:
2.63
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PORFIMER SODIUM
(1995)
Small molecule
DNA inhibitor
Unknown
Approved
Unknown
PORFIMER SODIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
Y3834SIK5F
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MUPIROCIN CALCIUM
(1995)
Small molecule
Isoleucyl-tRNA synthetase inhibitor
NASAL; TOPICAL
Approved
Infections
MUPIROCIN CALCIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
RG38I2P540
Molecule Type:
Small molecule
Molecular Formula:
C52H90CaO20
Molecular Weight:
1075.35
AlogP:
2.59
PSA:
146.05
HBD:
4.0
HBA:
#RotB:
16.0
Source:
CARVEDILOL
(1995)
Small molecule
Adrenergic receptor alpha-1 antagonist
ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Ventricular Dysfunction, Left
CARVEDILOL
×
Maximum Phase:
4
First Approval:
1995
UNII:
0K47UL67F2
Molecule Type:
Small molecule
Molecular Formula:
C24H26N2O4
Molecular Weight:
406.48
AlogP:
3.74
PSA:
75.74
HBD:
3.0
HBA:
#RotB:
10.0
Source:
ANASTROZOLE
(1995)
Small molecule
Cytochrome P450 19A1 inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
ANASTROZOLE
×
Maximum Phase:
4
First Approval:
1995
UNII:
2Z07MYW1AZ
Molecule Type:
Small molecule
Molecular Formula:
C17H19N5
Molecular Weight:
293.37
AlogP:
2.93
PSA:
78.29
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CISATRACURIUM
(1995)
Small molecule
Unknown
Unknown
Approved
Unknown
CISATRACURIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
QX62KLI41N
Molecule Type:
Small molecule
Molecular Formula:
C53H72N2O12+2
Molecular Weight:
929.16
AlogP:
8.07
PSA:
126.44
HBD:
0.0
HBA:
#RotB:
24.0
Source:
METFORMIN
(1995)
Small molecule
Unknown
Unknown
Approved
Diabetes Mellitus
METFORMIN
×
Maximum Phase:
4
First Approval:
1995
UNII:
9100L32L2N
Molecule Type:
Small molecule
Molecular Formula:
C4H11N5
Molecular Weight:
129.17
AlogP:
-1.03
PSA:
88.99
HBD:
4.0
HBA:
#RotB:
0.0
Source:
LOSARTAN
(1995)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
LOSARTAN
×
Maximum Phase:
4
First Approval:
1995
UNII:
JMS50MPO89
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClN6O
Molecular Weight:
422.92
AlogP:
4.27
PSA:
92.51
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AZELAIC ACID
(1995)
Small molecule
Unknown
TOPICAL
Approved
Acne Vulgaris; Erythema; Rosacea
AZELAIC ACID
×
Maximum Phase:
4
First Approval:
1995
UNII:
F2VW3D43YT
Molecule Type:
Small molecule
Molecular Formula:
C9H16O4
Molecular Weight:
188.22
AlogP:
1.89
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
8.0
Source:
DIRITHROMYCIN
(1995)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections
DIRITHROMYCIN
×
Maximum Phase:
4
First Approval:
1995
UNII:
1801D76STL
Molecule Type:
Small molecule
Molecular Formula:
C42H78N2O14
Molecular Weight:
835.09
AlogP:
2.2
PSA:
196.33
HBD:
5.0
HBA:
#RotB:
12.0
Source:
SAQUINAVIR
(1995)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
SAQUINAVIR
×
Maximum Phase:
4
First Approval:
1995
UNII:
L3JE09KZ2F
Molecule Type:
Small molecule
Molecular Formula:
C38H50N6O5
Molecular Weight:
670.86
AlogP:
3.09
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
12.0
Source:
EPOPROSTENOL
(1995)
Small molecule
Unknown
Unknown
Approved
Thrombosis
EPOPROSTENOL
×
Maximum Phase:
4
First Approval:
1995
UNII:
DCR9Z582X0
Molecule Type:
Small molecule
Molecular Formula:
C20H32O5
Molecular Weight:
352.47
AlogP:
3.41
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
1
2
…
42
43
44
45
46
47
48
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA